Description
A potent, selective, ATP-competitive mTORC1/2 dual inhibitor (IC50 = 2.81 nM against the isolated recombinant enzyme); exhibits >1,000-fold selectivity against all PI3K isoforms; has broad antiproliferative effects across multiple cell lines, reduces tumor growth in in vivo models of ER+ breast cancer, and acts as a radiosensitizer
Formal name: 3-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-N-methyl-benzamide
Synonyms: Vistusertib
Molecular weight: 462.5
CAS: 1009298-59-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|mTOR||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling